Genexine Co., Ltd. - Product Pipeline Review - Q4 2010

Global Markets Direct, November 2010, Pages: 39

Genexine Co., Ltd. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Genexine Co., Ltd. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Genexine Co., Ltd. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Genexine Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Genexine Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Genexine Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Genexine Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Genexine Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Genexine Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Genexine Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Genexine Co., Ltd. and identify potential opportunities in those areas.

List of Tables
List of Figures
Genexine Co., Ltd. Snapshot
Genexine Co., Ltd. Overview
Key Information
Key Facts
Genexine Co., Ltd. – Research and Development Overview
Key Therapeutic Areas
Genexine Co., Ltd. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Genexine Co., Ltd. – Pipeline Products Glance
Genexine Co., Ltd. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Genexine Co., Ltd.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Genexine Co., Ltd. – Drug Profiles
GX-110
Product Description
Mechanism of Action
R&D Progress
GX-12 + HAART
Product Description
Mechanism of Action
R&D Progress
HB-110 + Adefovir
Product Description
Mechanism of Action
R&D Progress
GX-G3
Product Description
Mechanism of Action
R&D Progress
GX-G6
Product Description
Mechanism of Action
R&D Progress
GX-H9
Product Description
Mechanism of Action
R&D Progress
Genexine Co., Ltd. – Pipeline Analysis
Genexine Co., Ltd. – Pipeline Products by Therapeutic Class
Genexine Co., Ltd. Pipeline Products By Target
Genexine Co., Ltd. – Pipeline Products by Route of Administration
Genexine Co., Ltd. – Pipeline Products by Molecule Type
Genexine Co., Ltd. - Dormant Projects
Genexine Co., Ltd. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Genexine Co., Ltd., Deals Volume Summary, 2004 to YTD 2010
Genexine Co., Ltd., Deals Summary By Region, 2004 to YTD 2010
Genexine Co., Ltd., Deals Summary, 2004 to YTD 2010
Genexine Co., Ltd. Detailed Deal Summary
Genexine Enters Into Agreement With Kwang-Dong Pharma
IldongPharmaceutical Partners With Genexine
Genexine Enters Into Technology Transfer Agreement With Boryung Pharmaceuticals
Genexine Enters Into Technology Transfer Agreement With HANDOK Pharmaceuticals
Dong-A Pharmaceutical Enters Into Co-Development Agreement With Genexine
Genexine Enters Into Agreement With Kolon Life Science
Genexine Enters Into Agreement Wih Green Cross
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Charter Schools - Global Outlook
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report
• Aerospace and Defence Industry - Global Strategic Business Report